A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP (Q101333455)
Jump to navigation
Jump to search
scientific article published on 04 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP |
scientific article published on 04 November 2020 |
Statements
A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP (English)
Paul Coppo
Michael Bubenheim
Lionel Galicier
Sandrine Malot
Naïke Bigé
Pascale Poullin
François Provôt
Nihal Martis
Claire Presne
Olivier Moranne
Ruben Benainous
Antoine Dossier
Amélie Seguin
Miguel Hié
Alain Wynckel
Yahsou Delmas
Jean-François Augusto
Pierre Perez
Virginie Rieu
Christelle Barbet
François Lhote
Marc Ulrich
Anne Charvet Rumpler
Sten De Witte
Thierry Krummel
Agnès Veyradier
Ygal Benhamou
4 November 2020